Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction.
Xietao YeJiali LiuXinyao YuanSonghong YangYi HuangYan ChenPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
SMB mainly treats CI by regulating 94 proteins involved in lipid and atherosclerosis, chemical carcinogenesis-receptor activation, and IL-17 signaling pathway. Our research strategy provided a template for the drug development of TCM for the treatment of CI.